Markets:

Overview

News

Currencies

International

Treasuries

VivoPower PLC - Class A Ordinary Shares (NQ:VIVO)

4.900 +0.220 (+4.70%)

Streaming Delayed Price Updated: 1:22 PM EDT, Jul 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VivoPower PLC - Class A Ordinary Shares

< Previous 1 2 3 4 Next >

Looking Into Meridian Bioscience's Return On Capital Employed ↗

June 01, 2022

According to Benzinga Pro, during Q2, Meridian Bioscience (NASDAQ:VIVO) earned $28.75 million, a 87.43% increase from the preceding quarter. Meridian Bioscience also posted a total of $111.23 million...

Via Benzinga

This Company Looks To Make Its Value-Added Technologies Benefit Smartphone Consumers In China — Then The World? ↗

May 20, 2022

Photo by Deep Advani on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Cannabis Stock Gainers And Losers From May 19, 2022 ↗

May 19, 2022

GAINERS: Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed up 7.42% at $0.99

Via Benzinga

Marijuana Stock Movers For May 9, 2022 ↗

May 09, 2022

GAINERS: Item 9 Labs (OTC:INLB) shares closed up 9.00% at $1.09

Via Benzinga

Meridian Bioscience's Q2 Revenues Increase 30% To $111M, Highest In Company History ↗

May 06, 2022

Via Benzinga

Meridian Bioscience: Q2 Earnings Insights ↗

May 06, 2022

Meridian Bioscience (NASDAQ:VIVO) reported its Q2 earnings results on Friday, May 6, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For May 6, 2022 ↗

May 06, 2022

Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.

Via Benzinga

Why Meridian Bioscience's Shares Are Rising Today? ↗

February 04, 2022

Meridian Bioscience Inc (NASDAQ: VIVO) has posted

Via Benzinga

Cannabis Stock Movers For May 5, 2022 ↗

May 05, 2022

GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.62% at $0.01

Via Benzinga

Meridian Bioscience's Earnings: A Preview ↗

May 05, 2022

Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Meridian...

Via Benzinga

Bullish Sentiment Across The Cannabis Space - Check Full Movers For May 4, 2022 ↗

May 04, 2022

GAINERS: Nine Energy Service (NYSE:NINE) shares closed up 15.71% at $3.24

Via Benzinga

Marijuana Stock Movers For April 26, 2022 ↗

April 26, 2022

GAINERS: LOSERS: Leviathan Natural Prods (OTC:LVCNF) shares closed down 13.22% at $0.66

Via Benzinga

Cannabis Stock Gainers And Losers From April 22, 2022 ↗

April 22, 2022

GAINERS: MariMed (OTC:MRMD) shares closed up 5.59% at $0.72

Via Benzinga

Cannabis Stock Gainers And Losers From April 7, 2022 ↗

April 07, 2022

GAINERS: Origin Agritech (NASDAQ:SEED) shares closed up 15.34% at $8.42

Via Benzinga

Meridian Bioscience Earnings Perspective: Return On Capital Employed ↗

April 01, 2022

According to Benzinga Pro, during Q1, Meridian Bioscience (NASDAQ:VIVO) earned $15.34 million, a 130.43% increase from the preceding quarter. Meridian Bioscience also posted a total of $88.34 million...

Via Benzinga

Bull of the Day - Meridian Bioscience (VIVO) ↗

March 21, 2022

Meridian Bioscience is a $1 billion provider of diagnostic test kits for gastrointestinal and respiratory infectious diseases.

Via Talk Markets

Marijuana Stock Movers For March 16, 2022 ↗

March 16, 2022

GAINERS: MGC Pharmaceuticals (OTC:

Via Benzinga

Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers ↗

March 08, 2022

GAINERS: Nine Energy Service (NYSE:

Via Benzinga

Sail Through the Choppy Market With These 4 Low-Beta Stocks ↗

March 05, 2022

Creating a portfolio of low-beta stocks is important since the securities can deliver healthy returns and provide a shield against volatile market conditions.

Via Talk Markets

FingerMotion (Nasdaq: FNGR) Looks To Jump On Continued Chinese Smartphone Growth With New Products ↗

February 24, 2022

Photo by 张嘴 on Unsplash

Via Benzinga

Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold ↗

February 23, 2022

A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance.

Via Investor's Business Daily

Meridian Bioscience: Q1 Earnings Insights ↗

February 04, 2022

Meridian Bioscience (NASDAQ:VIVO) reported its Q1 earnings results on Friday, February 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures ↗

February 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Earnings Scheduled For February 4, 2022 ↗

February 04, 2022

Companies Reporting Before The Bell • Brookfield Business (NYSE:BBU) is estimated to report earnings for its fourth quarter.

Via Benzinga

Earnings Preview: Meridian Bioscience ↗

February 03, 2022

Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that Meridian...

Via Benzinga

Cannabis Stock Gainers And Losers From February 1, 2022 ↗

February 01, 2022

GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 58.51% at $0.16

Via Benzinga

Cannabis Stock Gainers And Losers From January 31, 2022 ↗

January 31, 2022

GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76

Via Benzinga

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗

January 31, 2022

The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.

Via Benzinga

Cannabis Stock Gainers And Losers From January 28, 2022 ↗

January 28, 2022

GAINERS: BioHarvest Sciences (OTC:CNVCF) shares closed up 19.61% at $0.33

Via Benzinga

Meridian Bioscience Inc (VIVO) Q4 2021 Earnings Call Transcript ↗

November 12, 2021

VIVO earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.